Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid.
Lipton
Allan
A
Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA. alipton@psu.edu
Colombo-Berra
Alejandro
A
Bukowski
Ronald M
RM
Rosen
Lee
L
Zheng
Ming
M
Urbanowitz
Gladys
G
D001847:Bone Diseases / Q000209:etiology*; D001859:Bone Neoplasms / Q000473:pathology / Q000556:secondary*; D001862:Bone Resorption / Q000517:prevention & control*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000473:pathology*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology*; D009362:Neoplasm Metastasis; D010014:Osteolysis / Q000209:etiology / Q000517:prevention & control; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid